Tanım

The autoimmune diseases treatment market in China in terms of revenue is set to grow by US$ 11 sırasında milyar 2021-2027, yıllık bileşik büyüme oranında büyüyor (CAGR) ile ilgili 27% tahmin dönemi boyunca, veri ve analiz şirketi StratejiHelix'e göre.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2017-2020 ve tahmin 2027 covering key market aspects like sales value for autoimmune diseases treatment. The China autoimmune diseases treatment market is segmented on the basis of product, type. Ürüne göre, it is categorized into biologics, and small molecule chemical drugs. The small molecule chemical drugs segment held the largest market share in 2020. Fakat, the biologics segment is expected to witness the highest CAGR during the forecast period. Türe göre, the autoimmune diseases treatment market is divided into immunoglobulin A Nephropathy (IgAN), multiple sclerosis (MS), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD), rheumatoid arthritis (RA), Sjogren’s syndrome (SS), and systemic lupus erythematosus (SLE).

The report has profiled some of the key players of the market such as UCB S.A., AbbVie Inc., GlaxoSmithKline plc., Janssen Pharmaceutica NV, Novartis International AG, Pfizer Inc., Roche Holding AG, Rongchang Pharmacy Co. Ltd..

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the autoimmune diseases treatment market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Ürün: biologics, and small molecule chemical drugs
Tip: immunoglobulin A Nephropathy (IgAN), multiple sclerosis (MS), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD), rheumatoid arthritis (RA), Sjogren’s syndrome (SS), and systemic lupus erythematosus (SLE)
Düşünülen Yıllar: bu rapor dönemi kapsamaktadır 2017 ile 2027

Paydaşlar için Temel Faydalar

Get a comprehensive picture of the China autoimmune diseases treatment market
Büyüme sektörlerini ve yatırım eğilimlerini belirleyin
Understand what the future of the autoimmune diseases treatment market in China looks like
Rekabet ortamını ve fırsat penceresini belirleyin

İçindekiler

1. Pazar Tanımı
2. Araştırma Metodolojisi
3. Piyasa verileri & Görünüm
3.1 Market değeri
3.2 Piyasa Değeri Tahmini
4. Autoimmune Diseases Treatment Market by Product
4.1 Biologics
4.2 Small Molecule Chemical Drugs
5. Autoimmune Diseases Treatment Market by Type
5.1 Immunoglobulin A Nephropathy (IgAN)
5.2 Multiple Sclerosis (MS)
5.3 Myasthenia Gravis (MG)
5.4 Neuromyelitis Optica Spectrum Disorder (NMOSD)
5.5 Rheumatoid Arthritis (RA)
5.6 Sjogren’S Syndrome (SS)
5.7 Systemic Lupus Erythematosus (SLE)
6. Şirket profilleri
6.1 UCB S.A.
6.2 AbbVie Inc.
6.3 GlaxoSmithKline plc.
6.4 Janssen Pharmaceutica NV
6.5 Novartis International AG
6.6 Pfizer, A.Ş..
6.7 Roche Holding AG
6.8 Rongchang Pharmacy Co., Ltd..
7. Ek
7.1 StratejiHelix Hakkında
7.2 Sorumluluk reddi beyanı